1.
Eur J Haematol
; 105(2): 231-233, 2020 Aug.
Article
in English
| MEDLINE
| ID: mdl-32268442
Subject(s)
Multiple Myeloma/drug therapy , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cisplatin/administration & dosage , Cyclophosphamide/administration & dosage , Doxorubicin/administration & dosage , Etoposide/administration & dosage , Humans , Multicenter Studies as Topic , Multiple Myeloma/diagnosis , Multiple Myeloma/mortality , Prognosis , Treatment Outcome , United Kingdom
2.